Fidson, Ohara Pharmaceutical Partner to Boost African Healthcare
Fidson Healthcare, a Nigerian pharmaceutical giant, has signed a Memorandum of Understanding (MoU) with Japanese firm Ohara Pharmaceutical at the Tokyo International Conference on African Development. The partnership aims to boost Africa's healthcare by scaling up local drug production, enhancing research, and reducing the continent's reliance on imported medicines.
The collaboration, initiated in 2019, focuses on technology transfer and innovation, with Ohara providing expertise in advanced manufacturing of generic medicines. This strategic alliance is set to deepen Fidson's capabilities in producing specialized medicines for various conditions, including critical therapeutic areas like pediatric oncology.
Plus234Feed summary based on reporting from Leadership Newspaper. Read the original report below.
Read full article
Continue on Leadership Newspaper
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
Nigerian Pharma Stocks Soar Over 100% Led by Fidson Healthcare
Nigeria Explores Innovative Tech to Boost Local Drug Production
NBRDA Partners for Local Production of HIV Drugs in Nigeria
Kogi State to Sign MoUs with 15 Pharmaceutical Companies
NAFDAC Urges Pharma Firms to Invest in Vaccine Production for Health Security
Global Fund Commits to Support Nigeria's Health Financing for UHC and Pandemic Preparedness
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
